Suppr超能文献

心脏移植中晶体溶液心肌保护的比较实验研究

Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation.

作者信息

Lima Melchior Luiz, Fiorelli Alfredo Inácio, Vassallo Dalton Valentim, Pinheiro Bruno Botelho, Stolf Noedir Antonio Groppo, Gomes Otoni Moreira

机构信息

Cardiovascular Foundation for St. Francis of Assisi, Belo Horizonte, MG, Brazil.

出版信息

Rev Bras Cir Cardiovasc. 2012 Jan-Mar;27(1):110-6. doi: 10.5935/1678-9741.20120016.

Abstract

BACKGROUND

There is a growing need to improve myocardial protection, which will lead to better performance of cardiac operations and reduce morbidity and mortality. Therefore, the objective of this study was to compare the efficacy of myocardial protection solution using both intracellular and extracellular crystalloid type regarding the performance of the electrical conduction system, left ventricular contractility and edema, after being subjected to ischemic arrest and reperfusion.

METHODS

Hearts isolated from male Wistar (n=32) rats were prepared using Langendorff method and randomly divided equally into four groups according the cardioprotective solutions used Krebs-Henseleit-Buffer (KHB), Bretschneider-HTK (HTK), St. Thomas-1 (STH-1) and Celsior (CEL). After stabilization with KHB at 37ºC, baseline values (control) were collected for heart rate (HR), left ventricle systolic pressure (LVSP), maximum first derivate of rise left ventricular pressure (+dP/dt), maximum first derivate of fall left ventricular pressure (-dP/dt) and coronary flow (CF). The hearts were then perfused at 10ºC for 5 min and kept for 2 h in static ischemia at 20ºC in each cardioprotective solution. Data evaluation was done using analysis of variance in completely randomized One-Way ANOVA and Tukey's test for multiple comparisons. The level of statistical significance chosen was P<0.05.

RESULTS

HR was restored with all the solutions used. The evaluation of left ventricular contractility (LVSP, +dP/ dt and -dP/dt) showed that treatment with CEL solution was better compared to other solutions. When analyzing the CF, the HTK solution showed better protection against edema.

CONCLUSION

Despite the cardioprotective crystalloid solutions studied are not fully able to suppress the deleterious effects of ischemia and reperfusion in the rat heart, the CEL solution had significantly higher results followed by HTK>KHB>STH-1.

摘要

背景

改善心肌保护的需求日益增长,这将使心脏手术表现更佳,并降低发病率和死亡率。因此,本研究的目的是比较使用细胞内和细胞外晶体类型的心肌保护溶液在经历缺血性停搏和再灌注后对心脏传导系统性能、左心室收缩力和水肿的影响。

方法

采用Langendorff法制备从雄性Wistar大鼠(n = 32)分离的心脏,并根据所用的心脏保护溶液随机等分为四组:克雷布斯 - 亨塞尔特缓冲液(KHB)、布雷tschneider - HTK(HTK)、圣托马斯 - 1(STH - 1)和赛尔西奥(CEL)。在37℃用KHB稳定后,收集心率(HR)、左心室收缩压(LVSP)、左心室压力上升的最大一阶导数(+dP/dt)、左心室压力下降的最大一阶导数(-dP/dt)和冠状动脉流量(CF)的基线值(对照)。然后将心脏在10℃灌注5分钟,并在每种心脏保护溶液中于20℃静态缺血2小时。使用完全随机单因素方差分析和Tukey多重比较检验进行数据评估。选择的统计学显著性水平为P<0.05。

结果

使用的所有溶液均使HR恢复。左心室收缩力(LVSP、+dP/dt和 -dP/dt)的评估表明,与其他溶液相比,CEL溶液治疗效果更好。分析CF时,HTK溶液对水肿的保护作用更好。

结论

尽管所研究的心脏保护晶体溶液不能完全抑制大鼠心脏缺血和再灌注的有害影响,但CEL溶液的效果显著更高,其次是HTK>KHB>STH - 1。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验